what is the core?
The Core is the world’s first and only partnership between a world-class academic institution and a leading nonprofit organization dedicated to a full-spectrum approach to ALS drug development. Our goal is to develop the first effective treatments, and ultimately a cure, for ALS.
CORE ACCOMPLISHMENTS
THE CORE has made significant progress toward better therapeutic options for ALS. These accomplishments are increasing the number and testing the feasibility of potential ALS therapies, improving possible diagnostic tools in the clinic, and expediting the transition of promising drug candidates into patient populations. Among its achievements, CORE researchers have:
- Tested >1700 chemical compounds and FDA approved drugs for other indications in our in vitro screening unit,
- Collaborated with >20 other academic groups and biotechs to assess their ALS compounds of interest in a range of pre-clinical models,
- Developed a novel blood-based biomarker for ALS, which we are now validating for diagnostic and prognostic purposes,
- Moved two potential ALS drugs, jacifusen and CK0801, to people with ALS, and
- Developed an in-house drug, Prosetin, which can penetrate the brain through straightforward oral administration, measurably rescue stressed motor neurons in all of our ALS models, provably engage a cellular pathway of interest across neurodegeneration.
“For the first time, ALS patients can directly participate in research that will move us toward therapies that actually work…The Core provides an immensely exciting opportunity to capitalize on decades of ALS advances and translate them into meaningful treatments now.”
Neil Shneider, MD, PhD, Director of the Eleanor and Lou Gehrig ALS Center at Columbia
RESEARCH NEWS
BREAKING NEWS
Dear Friends, BREAKING NEWS: The all-new drug developed by the Project ALS Therapeutics Core for the treatment of ALS, is now moving into Phase 1
Join Brooke in the Don’t Talk-A-Thon
“ALS research is the only hope we have, so anything we can do to raise money for ALS research is crucial. It directly impacts how
Join Brynley in the Don’t Talk-A-Thon
https://vimeo.com/825968452Brynley and the Kirchhoff family have continued to be a pillar in the ALS community. Brynley’s support for the annual Don’t Talk-A-Thon is one of
Join Avery in the Don’t Talk-A-Thon
Wondering how the Don’t Talk-A-Thon came to be? It all started with then 9-year-old Avery Niedrowski! After her grandfather was diagnosed with ALS, he lost
Join Desi in the Don’t Talk-A-Thon
Just because ALS robs you of your speech, doesn’t mean your voice can’t be heard. Join those, like Desi and her daughter, for the Don’t